|
|
| Monoclonal Antibodies in Cancer Therapy 2009-2024 |
|
| Table of Contents Published: 2009/05 Published by: Visiongain |
| Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ... |
| The Immune/Inflammatory Pipeline: A Strategic Review |
|
| Table of Contents Published: 2009/05 Published by: Decision Resources, Inc. |
| The current immune/inflammatory pipeline is over 375 drugs strong, with approximately 250 companies involved in these agents' development. Yet, despite this robust pipeline size, Decision Resources analysts do not believe that any one agent in development ... |
| The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III |
|
| Published: 2009/05 Published by: BioInformatics, LLC |
| The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III will help suppliers better understand how antibodies are used and how demand is impacted by scientific application. In addition, segmentation analysis and trend comparisons wi ... |
| US Markets for ENT and Bronchoscopy Devices 2009 |
|
| Table of Contents Published: 2009/05 Published by: Millennium Research Group |
| The US markets for ear, nose, and throat (ENT) and bronchoscopy devices will grow moderately through 2013. The ENT market will be far larger than the market for bronchoscopy devices and will also expand more rapidly, reaching a value of more than $360 mil ... |
| US Stem Cell Market Analysis |
|
| Table of Contents Published: 2009/05 Published by: RNCOS E-Services Pvt. Ltd. |
| US Stem Cell Market Analysis provides extensive research and thorough analysis of the current industry trends driving the growth of stem cell market in the US. This report highlights the emerging segments in the market alongwith their market potential to ... |
| Bone Grafts |
|
| Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc. |
| This report analyzes the US market for Bone Grafts in Millions of US$. The market for Bone Grafts is analyzed by the following segments: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Plat ... |
| Capitalizing on New Opportunities for Stem Cell Products |
|
| Table of Contents Published: 2009/04 Published by: BioInformatics, LLC |
| Capitalizing on New Opportunities for Stem Cell Products provides a roadmap for stem cell product suppliers to help navigate a landscape that is poised for change- and growth. This analysis was designed to guide suppliers in redirecting resources to new a ... |
| Chinese Markets for Antibiotics |
|
| Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co. |
| China' s demand for Antibiotics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply a ... |
| Companion Biomarkers in Drug Development |
|
| Table of Contents Published: 2009/04 Published by: Trimark Publications |
| This TriMark Publications report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. ... |
| European Markets for Orthopedic Biomaterials 2009 |
|
| Table of Contents Published: 2009/04 Published by: iData Research Inc. |
| In 2008, the combined European biomaterial market was worth ?271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Wit ... |
| Medical Biosensors Market 2008-2012 |
|
| Table of Contents Published: 2009/04 Published by: Infiniti Research Limited |
| A biosensor is a device which makes use of biological substances to indicate the absence or presence of a particular substance in the tested material. ... |
| Practical Guide to Finding Partners in Pharma and Biotech, 2nd edition |
|
| Table of Contents Published: 2009/04 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| CurrentPartnering' s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity. The report takes the reader th ... |
| Bioinformatics Markets |
|
| Table of Contents Published: 2009/03 Published by: Trimark Publications |
| The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications beli ... |
| Liquid Chromatography Markets (LC, HPLC and UHPLC) |
|
| Table of Contents Published: 2009/03 Published by: Kalorama Information |
| The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of componen ... |
| Mesenchymal Stem Cells, Advances & Applications |
|
| Table of Contents Published: 2009/03 Published by: BioInformant |
| This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research p ... |
| Option & Evaluation Agreements in Pharma and Biotech |
|
| Table of Contents Published: 2009/03 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. ... |
|
|